antibiotic g 418 has been researched along with Dementias, Transmissible in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Azzawi, ZAM; Arshad, H; Bourkas, MEC; Mehrabian, M; Patel, Z; Schmitt-Ulms, G; Watts, JC | 1 |
| Biasini, E; Bonetto, V; Chiesa, R; Harris, DA; Massignan, T; Solomon, IH; Stewart, RS | 1 |
2 other study(ies) available for antibiotic g 418 and Dementias, Transmissible
| Article | Year |
|---|---|
The aminoglycoside G418 hinders de novo prion infection in cultured cells.
Topics: Aminoglycosides; Animals; Cell Line; Cell Line, Tumor; Gentamicins; Mice; Prion Diseases; Prion Proteins; Prions; Protein Synthesis Inhibitors; PrPC Proteins; PrPSc Proteins | 2021 |
A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein.
Topics: Amebicides; Animals; Antibiotics, Antineoplastic; Biological Assay; Bleomycin; Cell Line; Cell Survival; Cinnamates; Drug Evaluation, Preclinical; Gentamicins; GPI-Linked Proteins; Humans; Hygromycin B; Mice; Mice, Transgenic; Phenotype; Prion Diseases; Prions; Protein Isoforms; PrPC Proteins; PrPSc Proteins; Stem Cells | 2010 |